An Expanding Chemogenomic Toolbox Gives Kinome Research a Welcome and Much Needed Boost
The human kinome includes 500+ druggable targets, with 35+ small molecule kinase inhibitors approved by the FDA since 2000. Remarkable. Despite the... Read More
Biological Validation of the BioMAP® Platform with Phenotypic Chemical Probes
Phenotypic chemical biology is the use of target-selective chemical probes and drugs in cell-based or in vivo assays for establishing target function... Read More
The Key to Designing a Kinase Screening Project
The key to designing any scientific study is to carefully define the question you are asking – and designing a kinase inhibitor... Read More
Kinome-wide Profiling of Existing Chemical Assets: A Powerful Strategy to Jump-start New Drug Discovery Programs
Kinase inhibitors are among the fastest growing classes of FDA-approved drugs, and it has been satisfying to see that three have now... Read More
DiscoverX and the SGC Partner to Make an Annotated Collection of >600 Kinase Inhibitors Freely Available
FREMONT, Calif., Feb. 29, 2016 /PRNewswire/ — DiscoverX Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and... Read More